Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections DOI Creative Commons
Zuowei Wang, Ling Li,

Ruiping Du

et al.

iScience, Journal Year: 2024, Volume and Issue: 28(1), P. 111557 - 111557

Published: Dec. 9, 2024

Language: Английский

Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination DOI Creative Commons
Dennis Schaefer-Babajew, Zijun Wang,

Frauke Muecksch

et al.

Nature, Journal Year: 2022, Volume and Issue: 613(7945), P. 735 - 742

Published: Dec. 6, 2022

Abstract Feedback inhibition of humoral immunity by antibodies was first documented in 1909 1 . Subsequent studies showed that, depending on the context, can enhance or inhibit immune responses 2,3 However, little is known about how pre-existing influence development memory B cells. Here we examined cell response individuals who received two high-affinity anti-SARS-CoV-2 monoclonal and subsequently doses an mRNA vaccine 4–8 We found that recipients produced antigen-binding neutralizing titres were only fractionally lower compared than control individuals. cells differed from those they predominantly expressed low-affinity IgM carried small numbers somatic mutations altered receptor binding domain (RBD) target specificity, consistent with epitope masking. Moreover, out 77 anti-RBD tested neutralized virus. The mechanism underlying these findings experiments mice germinal centres formed presence same dominated Our results indicate bias centre selection through distinct mechanisms: (1) lowering activation threshold for cells, thereby permitting abundant lower-affinity clones to participate response; (2) direct masking their cognate epitopes. This may part explain shifting profile elicited booster vaccinations 9

Language: Английский

Citations

108

Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2 DOI Open Access
Samantha Mackin, Pritesh Desai, Bradley Whitener

et al.

Nature Microbiology, Journal Year: 2023, Volume and Issue: 8(4), P. 569 - 580

Published: April 3, 2023

Language: Английский

Citations

86

Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection DOI Open Access
Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen

et al.

Nature Immunology, Journal Year: 2023, Volume and Issue: 24(10), P. 1711 - 1724

Published: Sept. 21, 2023

Language: Английский

Citations

73

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape DOI Creative Commons
Leander Witte, Viren A. Baharani, Fabian Schmidt

et al.

Nature Communications, Journal Year: 2023, Volume and Issue: 14(1)

Published: Jan. 19, 2023

Waves of SARS-CoV-2 infection have resulted from the emergence viral variants with neutralizing antibody resistance mutations. Simultaneously, repeated antigen exposure has generated affinity matured B cells, producing broadly receptor binding domain (RBD)-specific antibodies activity against emergent variants. To determine how might escape these antibodies, we subjected chimeric viruses encoding spike proteins ancestral, BA.1 or BA.2 to selection by 40 antibodies. We identify numerous examples epistasis, whereby in vitro selected and naturally occurring substitutions RBD epitopes that do not confer Wuhan-Hu-1 spike, so spikes. As few as 2 3 BA.5 nearly all substantial plasma most individuals. Thus, epistasis facilitates acquisition remained effective early omicron

Language: Английский

Citations

60

Evolution of antibody immunity following Omicron BA.1 breakthrough infection DOI Creative Commons
Chengzi I. Kaku, Tyler N. Starr, Pan-Pan Zhou

et al.

Nature Communications, Journal Year: 2023, Volume and Issue: 14(1)

Published: May 12, 2023

Understanding the longitudinal dynamics of antibody immunity following heterologous SAR-CoV-2 breakthrough infection will inform development next-generation vaccines. Here, we track SARS-CoV-2 receptor binding domain (RBD)-specific responses up to six months Omicron BA.1 in mRNA-vaccinated individuals. Cross-reactive serum neutralizing and memory B cell (MBC) decline by two- four-fold through study period. Breakthrough elicits minimal de novo BA.1-specific but drives affinity maturation pre-existing cross-reactive MBCs toward BA.1, which translates into enhanced breadth activity across other variants. Public clones dominate response at both early late time points breakthough infection, their escape mutation profiles predict newly emergent sublineages, suggesting that convergent continue shape evolution. While is limited our relatively small cohort size, these results suggest variant exposure evolution memory, supporting continued variant-based

Language: Английский

Citations

47

Immune imprinting and next-generation coronavirus vaccines DOI
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell

et al.

Nature Microbiology, Journal Year: 2023, Volume and Issue: 8(11), P. 1971 - 1985

Published: Nov. 6, 2023

Language: Английский

Citations

44

Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants DOI
Timothy S. Johnston,

Shuk Hang Li,

Mark M. Painter

et al.

Immunity, Journal Year: 2024, Volume and Issue: 57(4), P. 912 - 925.e4

Published: March 14, 2024

Language: Английский

Citations

38

Immune Imprinting and Implications for COVID-19 DOI Creative Commons
Zhiqian Zhou, Julia Barrett, Xuan He

et al.

Vaccines, Journal Year: 2023, Volume and Issue: 11(4), P. 875 - 875

Published: April 20, 2023

Immunological memory is the key source of protective immunity against pathogens. At current stage COVID-19 pandemic, heterologous combinations exposure to viral antigens during infection and/or vaccination shape a distinctive immunological memory. Immune imprinting, downside memory, might limit generation de novo immune response variant or next-generation vaccines. Here, we review mechanistic basis imprinting by focusing on B cell immunobiology and discuss extent which harmful, as well its effect SARS-CoV-2 vaccination.

Language: Английский

Citations

28

AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans DOI Open Access
Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci

et al.

Science Immunology, Journal Year: 2024, Volume and Issue: 9(94)

Published: April 5, 2024

Vaccine adjuvants increase the breadth of serum antibody responses, but whether this is due to generation antigen-specific B cell clones with distinct specificities or maturation memory that produce broadly cross-reactive antibodies unknown. Here, we longitudinally analyzed immune responses in healthy adults after two-dose vaccination either a virus-like particle COVID-19 vaccine (CoVLP), CoVLP adjuvanted AS03 (CoVLP+AS03), messenger RNA (mRNA-1273). CoVLP+AS03 enhanced magnitude and durability circulating CD4 + T responses. Antigen-specific cells group at day 42 correlated 6 months. induced which accumulated somatic hypermutations over months, resulting neutralization monoclonal antibodies. Furthermore, fraction neutralizing encoded by increased between These results indicate enhances antigenic clonal level induces progressive response.

Language: Английский

Citations

12

SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals DOI Creative Commons
Aurélien Sokal, Giovanna Barba–Spaeth, Lise Hunault

et al.

Immunity, Journal Year: 2023, Volume and Issue: 56(9), P. 2137 - 2151.e7

Published: Aug. 4, 2023

Language: Английский

Citations

22